| Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers C Sabba, G Pasculli, GM Lenato, P Suppressa, P Lastella, M Memeo, ... Journal of Thrombosis and Haemostasis 5 (6), 1149-1157, 2007 | 196 | 2007 |
| A long diagnostic delay in patients with hereditary haemorrhagic telangiectasia: a questionnaire-based retrospective study P Pierucci, GM Lenato, P Suppressa, P Lastella, V Triggiani, R Valerio, ... Orphanet Journal of Rare Diseases 7, 1-13, 2012 | 137 | 2012 |
| Health-related quality of life in a rare disease: Hereditary hemorrhagic telangiectasia (HHT) or Rendu–Osler–Weber Disease G Pasculli, F Resta, E Guastamacchia, L Di Gennaro, P Suppressa, ... Quality of Life Research 13, 1715-1723, 2004 | 112 | 2004 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ... The Lancet 399 (10326), 719-728, 2022 | 102 | 2022 |
| Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: echo-color-Doppler vs multislice computed tomography study P Buonamico, P Suppressa, GM Lenato, G Pasculli, F D’Ovidio, M Memeo, ... Journal of Hepatology 48 (5), 811-820, 2008 | 101 | 2008 |
| Life expectancy in patients with hereditary haemorrhagic telangiectasia C Sabba, G Pasculli, P Suppressa, F D'ovidio, GM Lenato, F Resta, ... Journal of the Association of Physicians 99 (5), 327-334, 2006 | 94 | 2006 |
| Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia E Buscarini, LM Botella, U Geisthoff, AD Kjeldsen, HJ Mager, F Pagella, ... Orphanet Journal of Rare Diseases 14, 1-14, 2019 | 89 | 2019 |
| Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: results of a real-world clinical experience in Italy L D’Erasmo, AB Cefalù, D Noto, A Giammanco, M Averna, P Pintus, ... Advances in therapy 34, 1200-1210, 2017 | 81 | 2017 |
| Screening for children from families with Rendu–Osler–Weber disease: from geneticist to clinician P Giordano, A Nigro, GM Lenato, G Guanti, P Suppressa, P Lastella, ... Journal of Thrombosis and Haemostasis 4 (6), 1237-1245, 2006 | 81 | 2006 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 78 | 2017 |
| Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children P Giordano, GM Lenato, P Suppressa, P Lastella, F Dicuonzo, ... The Journal of Pediatrics 163 (1), 179-186. e3, 2013 | 77 | 2013 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 76 | 2017 |
| Subclinical hypothyroidism and cognitive dysfunction in the elderly F Resta, V Triggiani, G Barile, M Benigno, P Suppressa, V A Giagulli, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2012 | 63 | 2012 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 51 | 2018 |
| AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects C De Matteis, M Cariello, G Graziano, S Battaglia, P Suppressa, ... Scientific Reports 11 (1), 14834, 2021 | 48 | 2021 |
| DHPLC‐based mutation analysis of ENG and ALK‐1 genes in HHT Italian population GM Lenato, P Lastella, MC Di Giacomo, N Resta, P Suppressa, G Pasculli, ... Human Mutation 27 (2), 213-214, 2006 | 47 | 2006 |
| Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs. M Memeo, SI AA, A Scardapane, P Suppressa, A Cirulli, C Sabba, ... La Radiologia Medica 109 (1-2), 125-138, 2005 | 43 | 2005 |
| European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) OF Eker, E Boccardi, U Sure, MC Patel, S Alicante, A Alsafi, N Coote, ... Orphanet Journal of Rare Diseases 15, 1-10, 2020 | 42 | 2020 |
| Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia CL Shovlin, CM Millar, F Droege, A Kjeldsen, G Manfredi, P Suppressa, ... Orphanet Journal of Rare Diseases 14, 1-8, 2019 | 41 | 2019 |
| The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care CL Shovlin, E Buscarini, C Sabbà, HJ Mager, AD Kjeldsen, F Pagella, ... European Journal of Medical Genetics 65 (1), 104370, 2022 | 38 | 2022 |
